Conference LibraryGated
Kelonia Therapeutics · KLN-1010 (per ASGCT 2025 abstracts)
Kelonia Therapeutics · in vivo cell therapy 公司 · KLN-1010 是主要 pipeline (per OPORD-002 P1 verify list · ASGCT 2025 abstract anchor)。 Independent · 未被收购。Modality / target / clinical stage 待 ROLLCELL fetch ASGCT 2025 abstract DB verify。
- Type
- company
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- C
- category
- in_vivo_cell_therapy
- status
- draft
- instance_tag
- sunvax-antibody-2025
- threat_level
- complementary
- competes_dimensions
- in_vivo_cell_engineering
- platform_tech
- in vivo cell therapy (modality TBD)
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.